Two Sigma Securities’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-800
Closed -$404K 2370
2024
Q3
$404K Sell
800
-200
-20% -$97.2K 0.01% 1488
2024
Q2
$487K Buy
+1,000
New +$502K 0.01% 1573
2024
Q1
Sell
-1,200
Closed -$666K 3252
2023
Q4
$666K Buy
1,200
+300
+33% +$141K 0.01% 1334
2023
Q3
$394K Sell
900
-600
-40% -$299K ﹤0.01% 1713
2023
Q2
$753K Buy
+1,500
New +$719K 0.01% 1160
2023
Q1
Sell
-2,600
Closed -$1.06M 2937
2022
Q4
$1.06M Buy
2,600
+1,000
+63% +$388K 0.03% 662
2022
Q3
$521K Buy
1,600
+600
+60% +$220K 0.02% 1070
2022
Q2
$351K Sell
1,000
-1,000
-50% -$408K 0.01% 1170
2022
Q1
$1.09M Buy
+2,000
New +$1.05M 0.04% 572

Other funds holding IDXX

Two Sigma Securities's IDXX Position: Q2 2026 in Review

Two Sigma Securities increased its Idexx Laboratories (IDXX) stake by 166% in Q2 2026, buying an estimated $923K and bringing the position to 2,636 shares worth $1.39M. The position accounts for 0.12% of the portfolio, ranked #190.

Two Sigma Securities first reported a position in IDXX in Q1 2017 and has held it in 23 quarters since. The position peaked at $1.68M in Q3 2017. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Two Sigma Securities held 2,636 shares of Idexx Laboratories worth $1.39M as of Q2 2026.
  • Two Sigma Securities bought 1,645 Idexx Laboratories shares in Q2 2026, an estimated $923K.
  • Idexx Laboratories made up 0.12% of Two Sigma Securities's portfolio in Q2 2026, its #190 holding.
  • Two Sigma Securities first reported a position in Idexx Laboratories in Q1 2017 and has held it in 23 quarters since.
  • Two Sigma Securities's Idexx Laboratories position peaked at $1.68M in Q3 2017.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.